Nureca Ltd - Stock Valuation and Financial Performance

BSE: 543264 | NSE: NURECA | Medical Equipment/Supplies/Accessories | Small Cap

Nureca Ltd. Share Price

255.15 -14.95 -5.53%
as on 28-Mar'24 16:01

DeciZen - make an informed investing decision on Nureca Ltd.

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Somewhat Undervalued

3. Price Trend

Nureca stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
255.2 Cr.
52-wk low:
265.3
52-wk high:
468.3

Is Nureca Ltd an attractive stock to invest in?

1. Is Nureca Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Nureca Ltd is a good quality company.

2. Is Nureca Ltd undervalued or overvalued?

The key valuation ratios of Nureca Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

3. Is Nureca Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Nureca Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Nureca Ltd.:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Nureca Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 67.7%59.3%56%50.5%24.5%-4%-
Value Creation
Index
3.83.23.02.60.8-1.3-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 0.60.799.421325611296
Sales YoY Gr.-23.7%13,520.6%114.6%19.8%-56.2%-
Adj EPS 2.22.8911.646.644.7-8.40.2
YoY Gr.-26.5%32226.6%-94.9%-4.1%-118.7%-
BVPS (₹) 3.36.41,995.7163.3203.7195.3197.2
Adj Net
Profit
006.446.644.7-8.40
Cash Flow from Ops. 00.1-7.935.11.812.1-
Debt/CF from Ops. 00-1.200.60.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA185.5%4%-56.2%
Adj EPS NA-230.3%-120.9%-118.7%
BVPSNA126.6%-53.9%-4.2%
Share Price - - -24.7% -15.2%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
60.454.48552.324.4-4.20.1
Op. Profit
Mgn %
4.24.49.829.422.1-13.5-10.6
Net Profit
Mgn %
2.72.76.421.917.5-7.50.2
Debt to
Equity
000.7000-
Working Cap
Days
03606283130291332
Cash Conv.
Cycle
0104413858141317

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to 0.10%

Sales growth has been subdued in last 3 years 4.02%

Net Profit has been subdued in last 3 years -120.93%

Sales growth is not so good in last 4 quarters at -25.33%

Latest Financials - Nureca Ltd.

Standalone Consolidated
TTM EPS (₹) 0.2 0.8
TTM Sales (₹ Cr.) 96.2 96.2
BVPS (₹.) 197.2 197.2
Reserves (₹ Cr.) 187 187
P/BV 1.29 1.29
PE 0.00 310.41
From the Market
52 Week Low / High (₹) 265.25 / 468.25
All Time Low / High (₹) 265.25 / 2316.60
Market Cap (₹ Cr.) 255
Equity (₹ Cr.) 10
Face Value (₹) 10
Industry PE 59.3

Management X-Ray of Nureca Ltd.:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Nureca Ltd.

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales1199213256112
Operating Expenses 1190152200127
Manufacturing Costs000000
Material Costs01659913378
Employee Cost 00351016
Other Costs 0022485734
Operating Profit 00106256-15
Operating Profit Margin (%) 4.2%4.4%9.8%28.9%21.8%-13.8%
Other Income 000387
Interest 001210
Depreciation 000012
Exceptional Items 000000
Profit Before Tax 0096261-11
Tax 0021616-3
Profit After Tax 0064745-8
PAT Margin (%) 2.7%2.8%6.4%21.8%17.7%-7.5%
Adjusted EPS (₹)2.23.0915.746.545.3-8.4
Dividend Payout Ratio (%)0%0%0%4%7%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 0014163204195
Share Capital 000101010
Reserves 0014153194185
Minority Interest000000
Debt009100
Long Term Debt009100
Short Term Debt000000
Trade Payables016955
Others Liabilities 00527444
Total Liabilities 0134200252204

Fixed Assets

Gross Block00141111
Accumulated Depreciation000023
Net Fixed Assets0013108
CWIP 000000
Investments 00013462
Inventories0116376333
Trade Receivables0013034
Cash Equivalents 0001268471
Others Assets003325826
Total Assets 0134200252204

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 00-835212
PBT 0096261-11
Adjustment 0010-4-4
Changes in Working Capital 00-18-12-3831
Tax Paid 000-15-18-4
Cash Flow From Investing Activity 000-110-3-18
Capex 0000-60
Net Investments 000-109-1-17
Others 000-14-1
Cash Flow From Financing Activity 00892-7-2
Net Proceeds from Shares 00010500
Net Proceeds from Borrowing 009-13-10
Interest Paid 00-1-100
Dividend Paid 0000-50
Others 0001-1-1
Net Cash Flow 00017-9-8
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)68.3661.4791.4852.524.69-4.22
ROCE (%)103.8592.417667.7433.61-5.25
Asset Turnover Ratio1.750.95.661.921.190.51
PAT to CFO Conversion(x)NANNAN-1.330.740.04N/A
Working Capital Days
Receivable Days87682411211
Inventory Days80241324368150
Payable Days23152920271923

Nureca Ltd Stock News

Nureca Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Nureca Ltd. on 28-Mar-2024 16:01 is ₹255.2.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 16:01 the market cap of Nureca Ltd. stood at ₹255.2.
The latest P/E ratio of Nureca Ltd. as of 28-Mar-2024 16:01 is 0.00.
The latest P/B ratio of Nureca Ltd. as of 28-Mar-2024 16:01 is 1.29.
The 52-week high of Nureca Ltd. is ₹468.2 and the 52-week low is ₹265.2.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Nureca Ltd. is ₹96.17 ( Cr.) .

About Nureca Ltd

Nureca is a B2C company engaged in the business of home healthcare and wellness products, which offers quality, durability, functionality, usability and innovative designs. It enables its customers with tools to help them monitor chronic ailments and other diseases, to improve their lifestyle. It is a digital first company wherein it sells its products through online channel partners such as e-commerce players, distributors and retailer. Further, it also sells its products through its own website drtrust.in. 

The company has most of the product lines supporting home health market in India, making it a one-stop solution provider. Dr Trust is a known for its innovative products in the market, and, with the segment showing significant potential for growth, the company is positioned to show significant growth.

The company has a diversified product portfolio, which primarily caters to home healthcare sector. It provides an improved product mix to its customers and their preferences thereby targeting a wider customer base. Its growth is further driven by its ability to make available an assortment of quality products under trusted brands built by the company.

Products:

Currently, the company classify its products portfolio under the following five categories such as:

  • Chronic Device Products - which includes products such as blood pressure monitors, pulse oximeters, thermometers, nebulizers, self monitoring glucose devices, humidifier and steamers.
  • Orthopedic Products - which includes rehabilitation products such as wheelchairs, walkers, lumbar and tailbone supports and physiotherapy electric massagers.
    Mother and Child Products - which includes products such as breast pumps, bottle sterilizers, bottle warmers, car seats and baby carry cots.
  • Nutrition Supplements - which includes products such as fish oil, multivitamins, probiotics, botin, apple cider and vinegar.
  • Lifestyle Products - which includes products such as smart scales, aroma diffusers and fitness tracker.

Key awards, recognitions and accreditations

  • 2020: The company received ISO 9001:2015 Certificate of Registration from Intertek Certification Limited for Management System, which is applicable to sales, services and warehousing of medical devices, consumer electronics, pharmaceutical and personal care products.
  • 2020: Appreciation Letter from Pharmaceuticals Export Promoter Council of India stating the company as a very dynamic and evolving medical devices company and has created a credible and leading brand ‘Dr. Trust’ which is now a household name in India.

Major events and milestones:

  • 2016: Online launch of Dr. Trust Brand.
  • 2017: Launched Dr. Physio brand in electric massager categories and Trumom brand in mother and child care categories.
  • 2017: Started three flex centres in Punjab, Karnataka and Uttar Pradesh.
  • 2018: The company became the wholly owned subsidiary of Nectar Biopharma Private Limited.
  • 2018: Added three flex centres in Chandigarh, Telangana and Maharashtra.
  • 2018: Secured warehouse drug license.
  • 2020 Transfer and vesting of Specified Undertaking (as defined under the Scheme) from Nectar Biopharma Private Limited to the company pursuant to the Scheme of Arrangement.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.